Bortezomib, dexamethasone, cyclophosphamide and lenalidomide combination for newly diagnosed multiple myeloma: phase 1 results from the multicenter EVOLUTION study

✍ Scribed by Kumar, S K; Flinn, I; Noga, S J; Hari, P; Rifkin, R; Callander, N; Bhandari, M; Wolf, J L; Gasparetto, C; Krishnan, A

• Book ID: 109887154
• Publisher: Nature Publishing Group
• Year: 2010
• Tongue: English
• Weight: 302 KB
• Volume: 24
• Category: Article
• ISSN: 0887-6924
• DOI: 10.1038/leu.2010.116